trending Market Intelligence /marketintelligence/en/news-insights/trending/1_9ixtmeazusza7trgqavw2 content esgSubNav
In This List

Cancer Genetics appoints chief commercial officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cancer Genetics appoints chief commercial officer

Cancer Genetics Inc. appointed Michael McCartney as chief commercial officer, effective June 12.

McCartney will be responsible for developing and overseeing Cancer Genetics' commercial strategy and heading its business development initiatives. He previously served as CEO at SCIKON Innovation Inc.

Cancer Genetics develops, commercializes and provides molecular and biomarker-based tests and services in the U.S., India and China.